How a dental manufacturer enters the UK market

A dental product that is made well and sold well in your own country does not automatically sell in the UK.

Two things decide the outcome. The first is the official rules for placing the product on the market. The second is how well you understand the market you are entering. This article covers both.

This article is general information. It is not legal or regulatory advice, and Knightsbridge Academy is not a law firm.

Why is a good product not enough?

This section reflects Knightsbridge Academy's experience, not an official source.

The problem we meet most often is a simple belief. "Our product is better than the ones sold there. Why would it not sell?"

Quality matters. It is not the whole answer. Making a product well in your own country, for example in Türkiye, does not mean you can sell it in the UK without extra work. The market has its own habits, its own way of talking about brands and its own communication style.

How should you build a strategy for the UK?

Treat the UK as a new market, not as an extension of your home market. In our experience, a manufacturer should build a market and brand strategy around three things:

• The habits of the country. How do UK clinicians learn about, test and choose products?
• Brand language. How is your brand positioned against the ones clinicians already know?
• Communication language. Do your messages, materials and tone make sense to a UK reader?

Do this work before you spend money on a launch.

What is the official frame?

The rules below apply to Great Britain, which means England, Scotland and Wales. Northern Ireland has separate guidance ¹.

On 21 October 2026 the UK government published its response to a consultation on the recognition of CE marked devices. The consultation ran from 16 February to 10 April 2026 and received 1,056 responses ¹. The details below come from that response.

What about CE marking and UKCA marking?

The decisions are as follows ¹:

• EU MDR and IVDR devices. CE marked devices certified under the EU Medical Device Regulation and In Vitro Diagnostic Regulation will be recognised indefinitely.
• EU MDD devices. These will be accepted until the end of the EU transition period, which is currently 31 December 2028.
• UKCA marking. It remains available alongside CE recognition.
• A separate reliance route for devices classed higher in Great Britain than in the EU. The government does not intend to take this forward.

These decisions need legislation. The government says the changes will be made before the end of the earliest relevant transition period, which is 30 June 2028, and that they are subject to parliamentary approval ¹.

Because these rules are changing, check the current GOV.UK and MHRA pages before you decide on your route.

What still applies to every manufacturer?

Recognition of the CE mark does not remove the other duties. The government response confirms that ¹:

• MHRA registration. The manufacturer, or its UK Responsible Person, must continue to register devices with the MHRA.
• A UK Responsible Person (UKRP). A manufacturer based outside the UK must appoint one for devices on the UK market.
• Post-market surveillance. Strengthened requirements have been in force since June 2025.
• English documents. Technical documentation and certificates of conformity must be available in English.
• Enforcement notices. Manufacturers must comply with notices issued under the Medicines and Medical Devices Act 2021.

The MHRA remains responsible for monitoring the safety of all medical devices in the UK ¹.

What should you check before you start?

This list comes from the official obligations above, not from our own observation.

• Is your product a medical device under UK rules?
• Which marking route will you use: CE or UKCA?
• Have you appointed a UKRP, if you are based outside the UK?
• Is the device registered with the MHRA?
• Are your technical files and certificates available in English?
• Do you have a plan for post-market surveillance?
• Have you checked the separate Northern Ireland guidance, if you plan to sell there?

Fees and processing times are not given in the official response. Check the MHRA pages for the current position.

What should you do next?

• Confirm your product's regulatory status with the MHRA guidance or a regulatory adviser.
• Choose and brief your UKRP.
• Build a UK market and brand strategy before you plan a launch.

Knightsbridge Academy's page for dental manufacturers entering the UK market explains how we work with companies on this.

References

1. GOV.UK. Government response to the targeted consultation on indefinite recognition of CE marked medical devices, 21 October 2026. https://assets.publishing.service.gov.uk/media/6ad76f8be9713babfbe3f755/Government_response_to_the_targeted_consultation_on_indefinite_recognition_of_CE_marked_medical_devices.pdf

Last reviewed: November 2026

Internal links

• Dental manufacturers UK market entry (dental-manufacturers-uk-market-entry.html)
• Consultancy hub
• Buying or opening a dental practice in the UK

Image idea

A dental product on a display stand at a UK dental exhibition, or a product box with a clean UK-style label. Use our own archive photos or a neutral stock image. No logos.

Open points (not for publication)

• The whole regulatory section rests on one official source, the 21 October 2026 government response. Please check the MHRA pages once more before publishing, because the legal changes are not yet made.
• The "Why is a good product not enough" and "How should you build a strategy" sections reflect Dr Manav's experience, not an official source. They are marked in the text.
• MHRA registration fees, UKRP fees, risk class rules and processing times are left out on purpose. No reliable current figures were found.
• Closing page: Dr Manav asked for the investors section. The page named in the series brief for companies is "Dental manufacturers UK market entry". It is used here. Please confirm that this is the right page.
• Nothing is said about distributors, exhibitions or course-based product training, because no official source supports it.